Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Methylchloroisothiazolinone is an isothiazolinone compound widely used as a preservative with antibacterial and antifungal properties. It is commonly found in water-based personal care products, cosmetics, lotions, makeup removers, glues, detergents, paints, fuels, and other industrial processes[2][4][5]. Its primary mechanism of action involves the oxidation of thiol-containing residues in microorganisms via its active sulfur moiety—effectively killing most aerobic and anaerobic bacteria as well as yeast and fungi[5]. Methylchloroisothiazolinone is also a known dermatological sensitizer and allergen; it can cause contact dermatitis and was named Contact Allergen of the Year by the American Contact Dermatitis Society in 2013[1][2][5]. In medicine it is approved for use within allergenic epicutaneous patch tests to aid diagnosis of allergic contact dermatitis in individuals aged six years or older[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methylchloroisothiazolinone.